A randomized double blind, placebo controlled balanced 4-way crossover study to assess the efficacy of single oral doses of PF-00592379 on erectile function, using 100mg sildenafil as a positive control
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs PF 592379 (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- 20 Nov 2006 New trial record.